Managing Breathlessness in Persons with COVID-19: An Evidence Review of the Role of Opioids
Written by: Terri Maxwell PhD, APRN, Chief Clinical Officer, Turn-Key Health
Although most people with COVID-19 recover without needing specialist treatment, about one in six becomes seriously ill and develops difficulty breathing, most often due to pneumonia.
When the lungs become infected with coronavirus and filled with inflammatory material that inflame air sacs, the body’s ability to take on oxygen and get rid of carbon dioxide is reduced. This results in dyspnea, which is the subjective sensation of being unable to breathe.
Dyspnea varies in intensity, but when severe, it is one of the most uncomfortable symptoms that when left unrelieved can result in panic. Opioids, such as morphine, are effective at relieving dyspnea, but many physicians are reluctant to prescribe opioids for breathlessness except during the last days or weeks of life.
Turn-Key’s Quick Guide to Treating Dyspnea with Opioids provides a concise evidence review of how opioids relieve dyspnea, includes recommendations for starting doses and titration, describes the role of anxiolytics such as lorazepam and answers the question “do opioids hasten death?” (the answer is no).
Click here to download a copy of the guide!